... with locally advanced non -small celllungcancer treated with concurrent chemotherapy and intensity-modulated radiotherapy Radiation Oncology 2010, 5:35 Shi et al. Radiation Oncology 2010, 5:35http://www.ro-journal.com/content/5/1/35Open ... Hominal S, Cordier JF, Carrie C: A prospective study on radiation pneumonitis following conformal radiationtherapy in non -small- cell lung cancer: Clinical and dosimetric factors analysis. Radiother ... survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non- small- cell carcinoma of the lung. Int J Radiat...
... morphological characteristics ofpermanent human smallcelllungcancercell lines. J Cancer Res ClinOncol 1987, 113:31-40.16. NCCN guidelines for small- celllung cancer. [http://www.nccn.org/professionals/physician_gls/f_guidelines.asp].17. ... chemoradiation for limited smallcell lung cancer decreases survival and disease control. LungCancer 2001,33:249-258.26. Cisplatin, etoposide, and two different schedules of radiationtherapy ... limited-stage smallcelllung cancer. [http://clinicaltrials.gov/ct2/show/NCT00433563].27. Three different radiationtherapy regimens in treating patients withlimited-stage smallcelllung cancer...
... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.2. Non -small CellLungCancer Collaborative Group: Chemotherapyin non smallcelllung cancer: a meta-analysis ... JL:Gemcitabine plus docetaxel as first-line chemotherapy inpatients with advanced non -small celllung cancer: a lung cancer Galician group phase II study. Cancer Chemother Pharma-col 2007, 60:725-732.20. ... paclitaxel-cisplatin versus cisplatin-teniposide in patients withadvanced non -small- celllung cancer. The European Organi-zation for Research and Treatment of CancerLung Cancer Cooperative Group. J Clin...
... Non -small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell lung cancer: ... ofdetecting EGFR mutations in lungcancer patients.Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non -small- cell lungcancer (NSCLC) cell lines and tumor ... of human NSCLC cell lines and lung cancer patient tumor tissues. A score of 0 was considered negative, a score of 1was considered weakly positive, and a score of 2 or 3 was consideredstrongly...
... are often dividedinto two broad categories: smallcelllungcancer (SCLC) and non -small celllungcancer (NSCLC). All majorhistological types of lungcancer are associated with smoking, although ... act as a risk marker of lungcancer in Taiwan. Cancer 2003,97:1558-1563.11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. LungCancer 2009, 65:13-18.12. ... oesophagus, head andneck cancer. HPV has also been speculated to have a role in the pathogenesis of lung cancer. To validate thehypothesis of HPV involvement in smallcelllungcancer pathogenesis...
... marker expression in tumor cells versus stromal cells in non small celllung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lung and PleuralTumours. ... treated with adjuvant chemotherapy aftercomplete resection of non -small celllung carcinoma. Cancer Res 2010,70:8288-98.19. Goldstraw P:The 7th Edition of TNM in Lung Cancer: what now? J ThoracOncol ... innon -small celllung cancer. Clin Cancer Res 2008, 14:5220-7.30. Andersen S, Eilertsen M, Donnem T, et al: Diverging prognostic impacts ofhypoxic markers according to NSCLC histology. Lung Cancer...
... Staging of small cell and non -small celllung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer: ... breast cancer. Br J Cancer 2006,95(6):683-90.17. Cancer Research UK [http://www.cancerresearchuk.org]18. Cancer Help [http://www.cancerhelp.org.uk]19. Association for International Cancer ... Research and Treatment of Cancer Quality-of-Life Questionnaire -Lung Cancer- 17items; EQ-5D: EuroQoL-5 Dimensions; HRQL: Health-related Quality of Life; NSCLC: Non -Small CellLung Can-cer; SF-36:...
... the leading cause of cancer death world-wide (1). Lungcancer is generally classified into two histological types, smallcelllungcancer (SCLC) and non smallcelllungcancer (NSCLC). NSCLC ... gefitinib in non -small celllungcancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non -small- celllungcancer patients ... in non -small cell lungcancer Is correlated with survival. Clin Cancer Res. 2001; 7(7): 1850-5. 93. Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated non -small- celllung cancer...
... patients with inoperable non smallcelllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, preoperative chemotherapy orradiotherapy might offer a ... AccessPathological complete response induced byfirst-line chemotherapy with single agentdocetaxel in a patient with advanced non small celllung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, ... few cycles should notautomatically discourage to continue treatment.IntroductionIn non -small celllungcancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ofseverity....
... Steep dose-responserelationship for stage I non -small- celllungcancer usinghypofractionated high-dose irradiation by real-time tumor-trackingradiotherapy. Int J Radiat Oncol Biol Phys 2009, 70:374-381.4. ... prediction in primary radiotherapy of non -small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389.16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment ... Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non -small celllung cancer. LungCancer 2003,41:1-11.17. Shibamoto Y, Yukawa Y, Tsutsui K, Takahashi M, Abe M: Variation...
... smallcelllungcancer (NSCLC) includes palliative systemicchemotherapy and/or radiotherapy. Recent studies of patients with limited metastases treated with curative-intentstereotactic body radiation ... Aggressive local therapy may be indicated in these patients, though prospectiveclinical studies are needed.Keywords: Stereotactic Body Rad iotherapy, Oligometastases, Non -Small CellLung Cancer BackgroundNon -small ... iotherapy, Oligometastases, Non -Small CellLung Cancer BackgroundNon -small celllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients with stage IV NSCLC...
... stereotactic body radiotherapy for stage Inon -small celllung cancer. Radiother Oncol 2007, 85:429-434.39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the ... surgery in patients withoperable lung cancer. A randomized phase III trial of Radiosurgery Or Surgeryfor operable Early stage (stage 1A) non -small cell Lung cancer (ROSEL, ClinicalTrials.gov ... for citation purposes) Radiation OncologyOpen AccessStudy protocolRecommendations for implementing stereotactic radiotherapy in peripheral stage IA non -small celllung cancer: report from the...
... atomic energy agency (IAEA)consultants' meeting on elective nodal irradiation in lung cancer: non -small celllungcancer (NSCLC). Int J Radiat OncolBiol Phys 2008, 72(2):335-342.6. Therasse ... electivenodal irradiation be omittd inStage III non -small celllung cancer? An analysis of recur-rences in a phase II study of induction chemotherapy andinvolved-field radiotherapy. Int J Radiat ... of irradiation technique and tumorextent in tumor control and survival of patients with unre-sectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group. Cancer...
... limited-disease smallcelllung cancer; PS, performance status; EP, etoposide; CDDP, cisplatin; XRT, thoracic radiotherapy; BID; bis in die/twice a day; CPT-11, irinotecan; PCI, prophylactic cranial irradiation.*PCI ... phase III trial comparing two types of consolidationchemotherapy after concurrent chemoradiotherapy for limited-disease smallcelllung cancer. RTrequirements included a total dose of 45 Gy/30 ... phase III trial comparingtwo types of consolidation chemotherapy after concurrentchemoradiotherapy for limited-disease smallcell lung cancer (Figure 1).The primary endpoint of JCOG 0202 was...
... for non -small- celllung cancer (NSCLC), where a continuous tumor regression duringradiotherapy was observed [9].This continuous tumor regression during radiotherapymakes adaptive radiotherapy ... for citation purposes) Radiation OncologyOpen AccessResearchEvalution of surface-based deformable image registration for adaptive radiotherapy of non -small celllungcancer (NSCLC)Matthias ... WagnerTH, Langen KM: Serial megavoltage CT imaging during exter-nal beam radiotherapy for non -small- celllung cancer: obser-vations on tumor regression during treatment. Int J RadiatOncol...